 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Bafna Pharmaceuticals Ltd at its meeting held on June 17, 2016, considered and approved the proposal for Allotment of Equity Shares of 10,00,000 to Promoters and 30,00,000 Equity Shares to External investors (Non-Promoter) under Preferential allotment basis through Postal Ballot Process.
Shares of BAFNA PHARMACEUTICALS LTD. was last trading in BSE at Rs.30.15 as compared to the previous close of Rs. 28.8. The total number of shares traded during the day was 90209 in over 641 trades.
The stock hit an intraday high of Rs. 31.35 and intraday low of 29.6. The net turnover during the day was Rs. 2762364.